Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells

Molecular Pharmacology

Volumn 49, Issue 2, 1996, Pages 311-318

  Schuetz, Erin G ^a   Beck, William T ^a   Schuetz, John D ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; GLYCOPROTEIN P; ISOSAFROLE; PHENOBARBITAL; RESERPINE; RIFAMPICIN;

ARTICLE; COLON CARCINOGENESIS; COLON CARCINOMA; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG TRANSPORT; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; BASE SEQUENCE; BLOTTING, NORTHERN; CELL LINE; CLOTRIMAZOLE; COLONIC NEOPLASMS; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; DNA PRIMERS; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDAZOLAM; MIXED FUNCTION OXYGENASES; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; P-GLYCOPROTEIN; PHENOBARBITAL; PHENYTOIN; POLYMERASE CHAIN REACTION; RIFAMPIN; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0030059953     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Moscow, J. A., and K. H. Cowan Multidrug resistance. J. Natl. Cancer Inst. 80:14-20 (1992).
2. Chin, K.-V., I. Pastan, and M. M. Gottesman. Function and regulation of the human multidrug resistance gene. Adv. Cancer Res. 60:157-180 (1993).
3. Thorgeirsson, S. S., J. A. Silverman, T W. Gant, and P. A. Marino. Multidrug resistance gene family and chemical carcinogens. Pharmacol. Ther. 49:283-292 (1991).
4. Teeter, L. D., D. D. Petersen, D. W. Nebert, and M. Tien Kuo. Murine mdr-1, mdr-2 and mdr-3 gene expression: no coinduction with the Cyp1A-1 and Nmo-1 genes in liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin. DNA Cell Biol. 10:433-441 (1991).
5. Schuetz, E. G., J. D. Schuetz, M. T. Thompson, R. A. Fisher, J. R. Madariage, and S. C. Strom. Phenotypic variability in induction of P-glycoprotein mRNA by aromatic hydrocarbons in primary human hepatocytes. Mol. Carcinog. 12:61-65 (1995).
6. Sonnichsen, D. S., Q. Liu, E. G. Schuetz, J D. Schuetz, A. Pappo, and M. V. Relling. Variability in human cytochrome P450 paclitaxel metabolism. J. Pharmacol. Exp. Ther. 275:566-575 (1995).
7. Relling, M. V., J. Nemec, E. G. Schuetz, J. D. Schuetz, F. J. Gonzalez, and K.R. Korzekwa. O-Demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Mol Pharmacol. 45:352-358 (1994).
8. Pichard, L., I. Fabre, G. Fabre, J. Domergue, B. Saint Aubert, G. Mourad, and P. Maurel. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab. Dispos. 18:595-606 (1990).
9. Smith, D. A., and B. C. Jones. Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes. Biochem. Pharmacol. 44:2089-2098 (1992).
10. Beck, W. T. Modulators of P-glycoprotein-associated multidrug resistance, in Molecular and Clinical Advances in Anticancer Drug Resistance (R. F. Ozols, ed.). Kluwer, Boston, 151-170 (1991).
11. Bellamy, W. T., W. S Dalton, and R. T. Dorr. The clinical relevance of multidrug resistance. Cancer Invest. 8:547-562 (1990).
12. Herzog, C. E., M. Toskos, S. E. Bates, and A. T. Fojo. Increased MDR-1/ P-glycoprotein expression after treatment of human colon carcinoma cells with p-glycoprotein antagonists. J. Biol. Chem. 268:2946-2952 (1993).
13. Ford, J. M., and W. N. Hait. Pharmacologic circumvention of multidrug resistance. Cytotechnology 12:171-212 (1993).
14. Kolars, J. C., K. S. Lown, P. Schmiedlin-Ren, M. Ghosh, C. Fang, S. A. Wrighton, R. M. Merion, and P. B. Watkins. CYP3A gene expression in human gut epithelium. Pharmacogenetics 4:247-259 (1994).
15. Shimada, T., H. Yamazake, M. Mimura, Y. Inui, and F. P. Guengerich. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:414-423 (1994).
16. Schuetz, E. G., J. D. Schuetz, S. C. Strom, M. T. Thompson, R. A. Fisher, D. T. Molowa, D. Li, and P. S. Guzelian. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 18:1254-1262 (1993).
17. Bhat, U. G., M. A. Winter, H. L. Pearce, and W. T. Beck. A structure-function relationship among reserpine/yohimbine analogs in their ability to increase expression of MDR1 and P-glycoprotein in a human colon carcinoma cell line. Mol. Pharmacol. 48:682-689 (1995).
18. Tom, B. H., L. P. Rutzky, and M. M. Jakstys. Human colonic adenocarcinoma cells. I. Establishment and description of a new line. In Vitro (Rockville) 12:180-191 (1976).
19. Beaune, P., P. Kremers, F. Letawe-Goujon, and J. E. Gielen. Monoclonal antibodies against human liver cytochrome P-450. Biochem. Pharmacol. 34:3547-3552 (1985).
20. Schuetz, E. G., D. Li, C. J. Omiecinski, U. Muller-Eberhard, H. K. Kleinman, B. Elswick, and P. S. Guzelian. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J. Cell. Physiol. 134:309-323 (1988).
21. Fairchild, C. R., S. P. Ivy, C.-S. Kao-Shan, J. Whang-Pheng, N. Rosen, M. A. Israel, P. W. Melera, K. H. Cowan, and M. E. Goldsmith. Isolation of amplified, and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res. 47:5141-5148 (1987).
22. Schuetz, J. D., S. Kauma, and P. S. Guzelian. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J Clin. Invest. 92:1018-1024 (1993).
23. Gonzalez, F J., B. J Schmid, M. Umeno, O. W. McBride, J. P. Hardwick, U. A Meyer, H. V. Gelboin, and J. R. Idle. Human P450PCN1: sequence, chromosome localization, and evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA (N. Y.) 7:79-86 (1988).
24. Schuetz, J. D., D. T. Molowa, and P. S. Guzelian. Characterization of a cDNA encoding a new member of the glucocorticoid-responsive cytochromes P450 in human liver. Arch. Biochem. Biophys. 274:355-365 (1989).
25. Schuetz, J. D., and P. S. Guzelian. Isolation of CYP3A5P cDNA from human liver: a reflection of a novel cytochrome P-450 pseudogene. Biochim. Biophys. Acta 1261:161-165 (1995).
26. Schuetz, J. D., D. L. Beach, and P. S. Guzelian. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4:11-20 (1994).
27. Schinkel, A. H., J. J. Smit, O. van Tellingen, J. H. Beijnen, E. Wagenaar, L. van Deemter, C. A. Mol, M. A. van der Valk, E. C. Robanus-Maandag, H. P. te Riele, A. J. M Berns, and P. Borst. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502 (1994).
28. Fojo, A., K. Ueka, D Slamon, D. Poplack, M. Gottesman, and I. Pastan. Expression of a multidrug resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84:265-269 (1987).
29. Thiebaut, F., T. Tsuruo, H. Hamada, M M. Gottesman, I. Pastan, and M. C Willingham. Cellular localization of the multidrug-resistance gene product p-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. USA 84:7735-7738 (1987).
30. Zhao, J.-Y., M. Ikeguchi, T. Eckersberg, and M. T. Kuo. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology 133:521-528 (1993).
31. Peters, W. H. M., and P. G. Kremers. Cytochromes P-450 in the intestinal mucosa of man. Biochem. Pharmacol. 38:1535-1538 (1989).
32. Bhat, U. G., and W. T. Beck. Functional and structural changes produced by reserpine in association with increased mdr1 expression in LS-180Ad human colon carcinoma cells (Abstract). Proc. Am. Assoc. Cancer Res. 36:1998 (1995).
33. Watkins, P. B., S A. Wrighton, E. G. Schuetz, D. T. Molowa, and P. S. Guzelian. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J. Clin. Invest. 80:1029-1036 (1987).
34. Kolars, J. C , P. Schmiedlin-Ren, J. D. Schuetz, C. Fang, and P. B. Watkins. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J. Clin. Invest. 90:1871-1878 (1992).
35. Carriere, V., T. Lesuffleur, A. Barbat, M. Rousset, E Dussaulx, P. Costet, I. de Waziers, P. Beaune, and A. Zweibaum. Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7. FEBS Lett. 355:247-250 (1994).
36. Wrighton, S. A., W. R. Brian, M.-A. Sari, M. Iwasaki, F. P. Guengerich, J. L. Raucy, D. T. Molowa, and M. Vandenbranden. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38:207-213 (1990).
37. Penny, J. I., and F. C. Campbell. Active transport of benzo(a)pyrene in apical membrane vesicles from normal human intestinal epithelium. Biochim Biophys. Acta 1226:232-236 (1994).
38. Augustijns, P. F., T. P. Bradshaw, L.-S. L. Gan, R. W. Hendren, and D. R. Thakker. Evidence for a polarized efflux system in CaCo-2 cells capable of modulating cyclosporin A transport. Biochem. Biophys. Res. Commun. 197:360-365 (1993).
39. Schinkel, A. H., E. Wagenaar, L. van Deemter, C. Mol, and P. Borst. Absence of the mdr1a p-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A J. Clin. Invest. 96:1698-1705 (1995).
40. Wils, P., V. Phung-Ba, A. Warnery, D. Lechardeur, S. Raeissi, I J. Hidalgo, and D. Scherman. Polarized transport of docetaxel and vinblastine mediated by P-glycoprotein in human intestinal epithelial cell monolayers. Biochem. Pharmacol. 48:1528-1530 (1994).
41. Lucey, M. R., J. C. Kolars, R. M. Merion, D. A. Campbell, M. Aldrich, and P. B. Watkins. Cyclosporin toxicity at therapeutic blood levels and cytochrome P450 IIIA. Lancet 335:11-15 (1990).
42. Hebert, M. F., J. P. Roberts, T. Prueksaritanont, and L. Z. Benet. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction. Clin. Pharmacol. Ther. 52:453-457 (1992).
43. Saeki, T., K. Ueda, Y. Tanigawara, R. Hori, and T. Komano. Human P-glycoprotein transports cyclosporin A and FK506. J. Biol. Chem. 268: 6077-6080 (1993).
44. Pichard, L., I. Fabre, G. Fabre, J. Domergue, B. Saint Aubert, G. Mourad, and P. Maurel. Cyclosporin A drug interactions: screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. Drug Metab. Dispos. 18: 595-606 (1990).